Pierre is currently the CEO of MRGN Advisors, Executive VP of CanSino Biologics,  Resgional partners at Merieux Equity Partners; Board Chairman and Non-Executive Director at Univercells.

He has a strong background in the pharmaceutical and biotechnology industries, with expertise in business development, strategic planning, and regulatory affairs.

• 

  Board member in Brenus Pharma

  New generation of precision medicine in oncology with proprietary STC platform designed to generate cancer-vaccines